Remove 2018 Remove Engineering Remove Regulations
article thumbnail

Epigenetic editing: the next generation of genetic medicine

Drug Target Review

The epigenome (meaning ‘above the genome’) is a system of reversible marks regulating how the DNA is read, translated and used. 2 Additionally, the epigenetic editing toolkit allows for precise temporal regulation. What is epigenetic editing? So, where does epigenetic editing currently stand and how will it transition into the clinic?

DNA 105
article thumbnail

Gamma delta T cells: a rising star in cancer therapy

Drug Target Review

These include engineering the cells to express cytokines that promote their maturation and/or differentiation, and engineering drug-resistant γδ T cells that can be combined with chemotherapies, which stress cancer cells but would otherwise also deplete the T-cell population. Trends Immunol 39(6):446-459 (2018).

Therapies 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Analysis Chemical Thank You The 103 regulations the EPA is currently working on

Agency IQ

The 103 regulations the EPA is currently working on On July 5, 2024, the EPA published its Spring 2024 Unified Agenda, which reveals what regulations the agency is planning on releasing by the end of the year and beyond.

article thumbnail

Farma: Speculative Gastronomy

Codon

Genetic engineering in the medicine cabinet is one thing; allowing it at the dinner table is another. Through genetic engineering, researchers have developed Golden Rice which can help address the problem of vitamin A deficiency , cotton that produces its own insecticide , virus-resistant papayas , and more. At the dining table.

article thumbnail

Condensate biology: advancing drug discovery for complex diseases

Drug Target Review

Dewpoint Therapeutics, a platform drug discovery company founded in 2018, has been at the forefront of this exciting field. As for regulatory considerations, Klein anticipates engaging in discussions with regulators to address novel aspects such as mechanism, toxicology, and dosing regimens.

Disease 98
article thumbnail

Human neuronal cells: possibilities in drug safety testing

Drug Target Review

The CiPA initiative aims to engineer an assay to assess the proarrhythmic potential of new drugs with improved specificity compared to current methods. Ther Innov Regul Sci. 2018 Mar;17(3):167–81. 2018 Dec 11;94(10):390–411. 2018;(136):56573. Regul Toxicol Pharmacol RTP. 2018;53(4):519–25. 2016;81:37–46.

Drugs 111
article thumbnail

Deciphering Another Secret of Life

NIH Director's Blog: Drug Discovery

Among those taking on this ambitious challenge is a recipient of a 2018 NIH Director’s New Innovator Award, Srivatsan Raman of the University of Wisconsin-Madison. 2] Engineering an allosteric transcription factor to respond to new ligands. Jarvis LM, Chemical & Engineering News. Trends Biochem Sci. 2008 Sep;33(9):420-425.